Update on ocular toxicity of ethambutol
African Vision and Eye Health
| Field | Value | |
| Title | Update on ocular toxicity of ethambutol | |
| Creator | Makunyane, Priscilla Mathebula, Solani | |
| Description | The purpose of this review is to update clinicians on available literature on the ocular toxicity of ethambutol and the type of eye care to be provided to patients treated with these medications. Ethambutol is a commonly used first-line anti-tuberculosis drug. Since its first use in the 1960s, ocular toxicity is described as related to dose and duration, and it is reversible on therapy discontinuation. However, the reversibility of the toxic optic neuropathy remains controversial. The mechanism of ocular toxicity owing to ethambutol is still under investigation. Other than discontinuing the drug, no specific treatment is available for the optic neuropathy caused by ethambutol. Doctors prescribing ethambutol should be aware of the ocular toxicity, and the drug should be used with proper patient education and ophthalmic monitoring. | |
| Publisher | AOSIS | |
| Date | 2016-08-30 | |
| Identifier | 10.4102/aveh.v75i1.353 | |
| Source | African Vision and Eye Health; Vol 75, No 1 (2016); 4 pages 2410-1516 2413-3183 | |
| Language | eng | |
| Relation |
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:
https://avehjournal.org/index.php/aveh/article/view/353/586
https://avehjournal.org/index.php/aveh/article/view/353/587
https://avehjournal.org/index.php/aveh/article/view/353/588
https://avehjournal.org/index.php/aveh/article/view/353/581
|
|
ADVERTISEMENT
